Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.
about
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.Dinosaurs and ancient civilizations: reflections on the treatment of cancerIn Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse ModelNeoplasia: the second decade.Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastasesMulti-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.The vasculature: a vessel for bone metastasis.Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.The War on Cancer rages on.Imaging response to systemic therapy for bone metastases.Imaging aspects of the tumor stroma with therapeutic implications.Monoclonal antibodies used as prophylactic, therapeutic and diagnostic agents.Anatomical and microstructural imaging of angiogenesis.Hypoxia-driven pathways in bone development, regeneration and disease.Targeting metastasis.Tumor Blood Vessel Visualization.Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.Quantitative assessment of microcirculation and diffusion in the bone marrow of osteoporotic rats using VCT, DCE-MRI, DW-MRI, and histology.Calibration of cone beam CT using relative attenuation ratio for quantitative assessment of bone density: a small animal study.IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis.Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.Multimodal imaging of bone metastases: From preclinical to clinical applicationsCombination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis
P2860
Q21142766-513CE071-24CF-44BA-854D-0E2D3AD7B449Q24628746-8C52E830-AB23-40D3-9B0D-33F26E3BA1AFQ27320156-39D1F499-A204-4EE7-9279-ADC5B3B5D432Q30484000-999901C4-3CF6-46DF-89E2-845532104367Q34561406-E8480FDD-3738-4106-B404-AC7A85ECB655Q36364700-B8183241-B6D4-47D2-BCA3-309E09A44918Q36879125-133BEB99-6FB1-43DB-8B6E-5DA37B3BA083Q36982114-212673AC-D575-4F9A-ACCB-802747BA99D4Q37102447-FBC55250-9209-43C6-A80F-1FF415AE06EBQ37478602-B368CB60-7158-4E12-ACE4-27753538CD0FQ37495608-263BEC15-680A-4B63-B1AC-95AB7B4D30A9Q37626064-4F1796B2-AB1F-4E97-B859-3226B2E504FBQ37701457-67B992FA-12F2-4C30-A3E5-D50A0AC85AD1Q37749573-23E0433D-934B-41E9-96DD-D0981C8FC1B7Q37997304-1D125A27-40B0-4600-8492-80478F7F0B27Q38786658-774E7544-F7D6-4975-81BE-C8782F44C576Q39178431-A97FD0BE-6E42-47AC-B1FF-64E2DAFF180AQ39677540-5D7A29DC-60DD-4487-AA8F-C59C7B17289FQ45766835-EBAFF626-3B56-4F41-A299-72DA300D4596Q46015323-94C10324-43A7-441F-9C88-C539992FED57Q49613885-4C9DBDF1-82AE-4374-B34B-B06066E02D07Q53646030-D0E78108-E052-424A-846E-8D4943105BDBQ56156782-8C6B398E-5FBA-46E4-BABD-AE3B5F4AE940Q58217157-462770AD-94FA-403E-B9B0-97800300769E
P2860
Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@ast
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@en
type
label
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@ast
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@en
prefLabel
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@ast
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@en
P2093
P2860
P50
P356
P1433
P1476
Bevacizumab inhibits breast ca ...... as visualized by VCT and MRI.
@en
P2093
Astrid Kersten
Fabian Kiessling
Heidegard Hilbig
Martin R Berger
Stefan Delorme
Sönke Bartling
Tobias Bäuerle
P2860
P304
P356
10.1593/NEO.08220
P577
2008-05-01T00:00:00Z